|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-9-12
|
|
pubmed:abstractText |
Transplantation is limited by a lack of human organ donors. Organs derived from animals, most likely the pig, represent a potential solution to this problem. For the heart, 90-day median graft survival of life-supporting pig hearts transplanted to nonhuman primates has been considered a reasonable standard for entry into the clinical arena. Overcoming the immune barrier to successful cardiac xenotransplantation is most appropriately first explored with the non-life-supporting heterotopic model.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD46,
http://linkedlifedata.com/resource/pubmed/chemical/Disaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/galactosyl-(1-3)galactose
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0022-5223
|
|
pubmed:author |
pubmed-author:ByrneGuerard WGW,
pubmed-author:DaviesWilliam RWR,
pubmed-author:KremersWalter KWK,
pubmed-author:LoganJohn SJS,
pubmed-author:McGregorChristopher G ACG,
pubmed-author:OiKeijiK,
pubmed-author:RisdahlJack MJM,
pubmed-author:SchirmerJohannes MJM,
pubmed-author:TazelaarHenry DHD,
pubmed-author:TeotiaSumeet SSS,
pubmed-author:WalkerRandall CRC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
130
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
844-51
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16153938-Animals,
pubmed-meshheading:16153938-Animals, Genetically Modified,
pubmed-meshheading:16153938-Antibodies,
pubmed-meshheading:16153938-Antigens, CD,
pubmed-meshheading:16153938-Antigens, CD46,
pubmed-meshheading:16153938-Disaccharides,
pubmed-meshheading:16153938-Graft Rejection,
pubmed-meshheading:16153938-Graft Survival,
pubmed-meshheading:16153938-Heart Transplantation,
pubmed-meshheading:16153938-Immunoglobulin G,
pubmed-meshheading:16153938-Immunoglobulin M,
pubmed-meshheading:16153938-Immunohistochemistry,
pubmed-meshheading:16153938-Immunosuppressive Agents,
pubmed-meshheading:16153938-Membrane Glycoproteins,
pubmed-meshheading:16153938-Myocardial Contraction,
pubmed-meshheading:16153938-Myocardium,
pubmed-meshheading:16153938-Papio,
pubmed-meshheading:16153938-Survival Rate,
pubmed-meshheading:16153938-Swine,
pubmed-meshheading:16153938-Transplantation, Heterologous,
pubmed-meshheading:16153938-Transplantation, Heterotopic
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Cardiac xenotransplantation: recent preclinical progress with 3-month median survival.
|
|
pubmed:affiliation |
Division of Cardiovascular Surgery, Department of Surgery, Mayo Clinic, Rochester, Minn 55905, USA. mcgregor.christopher@mayo.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
